[pending] PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0421-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
The recalled product
- Product
- PRAZOSIN HYDROCHLORIDE (PRAZOSIN HYDROCHLORIDE)
- Brand
- PRAZOSIN HYDROCHLORIDE
- Manufacturer
- Appco Pharma LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot:2406255UC
- Exp.: 2026/MAY
- 2406256UC
- Exp.: 2026/JUL
- 2407313UC Exp.: 2026/JUL
- 2408351UC
- 2408352UC
- 2509311UC
- Exp.: 2027/SEP. .
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PRAZOSIN HYDROCHLORIDE
- ModerateFDA Recalls Prazosin Hydrochloride Capsules Due to Temperature Storage Deviations
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27